75 related articles for article (PubMed ID: 35980291)
1. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis:
Das SS; Dubey AK; Verma PRP; Singh SK; Singh SK
Mol Pharm; 2022 Sep; 19(9):3367-3384. PubMed ID: 35980291
[TBL] [Abstract][Full Text] [Related]
2. Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
Afrin F; Chouhan G; Islamuddin M; Want MY; Ozbak HA; Hemeg HA
PLoS Negl Trop Dis; 2019 May; 13(5):e0007227. PubMed ID: 31071090
[TBL] [Abstract][Full Text] [Related]
3. In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
Khanra S; Juin SK; Jawed JJ; Ghosh S; Dutta S; Nabi SA; Dash J; Dasgupta D; Majumdar S; Banerjee R
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008575. PubMed ID: 32866156
[TBL] [Abstract][Full Text] [Related]
4. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
Kumar V; Kumari S; Ranjan R; Kumar A; Alti D
Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes.
Prajapat VM; Aalhate M; Sriram A; Mahajan S; Maji I; Gupta U; Kumari D; Singh K; Kalia NP; Dua K; Singh SK; Singh PK
Parasitol Int; 2024 Jun; 100():102848. PubMed ID: 38159836
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.
Corpas-Lopez V; Moniz S; Thomas M; Wall RJ; Torrie LS; Zander-Dinse D; Tinti M; Brand S; Stojanovski L; Manthri S; Hallyburton I; Zuccotto F; Wyatt PG; De Rycker M; Horn D; Ferguson MAJ; Clos J; Read KD; Fairlamb AH; Gilbert IH; Wyllie S
ACS Infect Dis; 2019 Jan; 5(1):111-122. PubMed ID: 30380837
[TBL] [Abstract][Full Text] [Related]
7. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
Corman HN; Ross JN; Fields FR; Shoue DA; McDowell MA; Lee SW
Microbiol Spectr; 2022 Dec; 10(6):e0265822. PubMed ID: 36342284
[TBL] [Abstract][Full Text] [Related]
8. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis.
Akbari M; Heli H; Oryan A; Hatam G
Pathog Glob Health; 2024 Feb; 118(1):40-46. PubMed ID: 37183476
[TBL] [Abstract][Full Text] [Related]
9. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Wyllie S; Brand S; Thomas M; De Rycker M; Chung CW; Pena I; Bingham RP; Bueren-Calabuig JA; Cantizani J; Cebrian D; Craggs PD; Ferguson L; Goswami P; Hobrath J; Howe J; Jeacock L; Ko EJ; Korczynska J; MacLean L; Manthri S; Martinez MS; Mata-Cantero L; Moniz S; Nühs A; Osuna-Cabello M; Pinto E; Riley J; Robinson S; Rowland P; Simeons FRC; Shishikura Y; Spinks D; Stojanovski L; Thomas J; Thompson S; Viayna Gaza E; Wall RJ; Zuccotto F; Horn D; Ferguson MAJ; Fairlamb AH; Fiandor JM; Martin J; Gray DW; Miles TJ; Gilbert IH; Read KD; Marco M; Wyatt PG
Proc Natl Acad Sci U S A; 2019 May; 116(19):9318-9323. PubMed ID: 30962368
[TBL] [Abstract][Full Text] [Related]
10. Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis.
Thapa R; Mondal S; Riikonen J; Rantanen J; Näkki S; Nissinen T; Närvänen A; Lehto VP
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009533. PubMed ID: 34185780
[TBL] [Abstract][Full Text] [Related]
11. Clotrimazole causes membrane depolarization and induces sub G
Paul A; Roy PK; Babu NK; Singh S
Acta Trop; 2024 Apr; 252():107139. PubMed ID: 38307362
[TBL] [Abstract][Full Text] [Related]
12. Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex.
Kwofie KD; Sato K; Sanjoba C; Hino A; Shimogawara R; Amoa-Bosompem M; Ayi I; Boakye DA; Anang AK; Chang KS; Ohashi M; Kim HS; Ohta N; Matsumoto Y; Iwanaga S
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007235. PubMed ID: 30908481
[TBL] [Abstract][Full Text] [Related]
13. Recent patents in the treatment and prevention of leishmaniasis.
Shahid SK
Pharm Pat Anal; 2023 Sep; 12(5):237-248. PubMed ID: 38063376
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell-derived human macrophages as an infection model for Leishmania donovani.
Baert L; Rudy S; Pellisson M; Doll T; Rocchetti R; Kaiser M; Mäser P; Müller M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011559. PubMed ID: 38166146
[TBL] [Abstract][Full Text] [Related]
15. HO-3867 Induces ROS-Dependent Stress Response and Apoptotic Cell Death in
Das A; Kamran M; Ali N
Front Cell Infect Microbiol; 2021; 11():774899. PubMed ID: 34926321
[TBL] [Abstract][Full Text] [Related]
16. Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
Osorio Y; Travi BL; Renslo AR; Peniche AG; Melby PC
PLoS Negl Trop Dis; 2011 Feb; 5(2):e962. PubMed ID: 21358812
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of 2-amino-thiophene derivative SB-200.
Sousa JPA; Sousa JMS; Rodrigues RRL; Nunes TAL; Machado YAA; Araujo AC; da Silva IGM; Barros-Cordeiro KB; Báo SN; Alves MMM; Mendonça-Junior FJB; Rodrigues KADF
Int Immunopharmacol; 2023 Oct; 123():110750. PubMed ID: 37536181
[TBL] [Abstract][Full Text] [Related]
18. New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.
Melo GD; Goyard S; Lecoeur H; Rouault E; Pescher P; Fiette L; Boissonnas A; Minoprio P; Lang T
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005924. PubMed ID: 28945751
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of rWnt5A in curbing
Maity S; Sengupta S; Sen M
Infect Immun; 2023 Oct; 91(10):e0026723. PubMed ID: 37725061
[TBL] [Abstract][Full Text] [Related]
20. Leishmania donovani Attenuates Dendritic Cell Trafficking to Lymph Nodes by Inhibiting C-Type Lectin Receptor 2 Expression via Transforming Growth Factor-β.
Yadav M; Akhtar MN; Mishra M; Kumar S; Kumar R; Shubham ; Nandal A; Sen P
Microbiol Spectr; 2023 Jun; 11(3):e0412222. PubMed ID: 37125906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
